A Short-Term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor α for Crohn's Disease-Reference-Cited by-同舟云学术

A Short-Term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor α for Crohn's Disease

Published:1997-10-09 Issue:15 Volume:337 Page:1029-1036
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Targan Stephan R.,Hanauer Stephen B.,van Deventer Sander J.H.,Mayer Lloyd,Present Daniel H.,Braakman Tanja,DeWoody Kimberly L.,Schaible Thomas F.,Rutgeerts Paul J.

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJM199710093371502

Cited by 2878 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The interplay between cytokines, inflammation, and antioxidants: mechanistic insights and therapeutic potentials of various antioxidants and anti-cytokine compounds;Biomedicine & Pharmacotherapy;2024-09

2. Treatment strategies for Spondyloarthritis: Implementation of precision medicine – Or “one size fits all” concept?;Autoimmunity Reviews;2024-09

3. Old and New Biologics and Small Molecules in Inflammatory Bowel Disease: Anti-Tumor Necrosis Factors;The Korean Journal of Gastroenterology;2024-08-25

4. Aktualisierte S3-Leitlinie „Diagnostik und Therapie des Morbus Crohn“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) (Version 4.1) – living guideline;Zeitschrift für Gastroenterologie;2024-08

5. Upadacitinib Reduces Crohn’s Disease Symptoms Within the First Week of Induction Therapy;Clinical Gastroenterology and Hepatology;2024-08